Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in pleural effusion and ascitis Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Does blind percutaneous pleural biopsy have a role in the investigation of pleural effusion? A pooled analysis Source: Annual Congress 2009 - Pleural diseases Year: 2009
Pleural fluid ‘cell block’ analysis in malignant pleural effusion: sensitive, superior over fluid cytology and suitable for immunohistochemistry analysis (IHC), will decrease need for thoracoscopy guided procedures Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
A comparative study of conventional cytology and cell block method in the diagnosis of malignant pleural effusion. Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018
Correlation between pleural cytology, radiolgy and histology in mesothelioma: a 3 year retrospective study Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007
Blind pleural biopsy in the study of undiagnosed pleural effusion: results and complications Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020
A randomised controlled study to compare the efficacy of closed pleural biopsy and medical thoracoscopic pleural biopsy in undiagnosed exudative pleural effusion Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Resolution of tuberculosis pleural effusions following anti-tuberculosis treatment alone – a retrospective study Source: Eur Respir J 2007; 30: Suppl. 51, 419s Year: 2007
Choice of pleural puncture site: Prospective comparative study between clinical exam and ultrasound Source: Virtual Congress 2020 – Use of thoracic ultrasound in different clinical settings Year: 2020
Prospective randomised trial of 'blind' Abram's pleural biopsies versus CT guided cutting needle biopsies in cytology negative undiagnosed pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 605s Year: 2002
Retrospective assessment of diagnostic yield of percutaneous transthoracic pleural biopsy in malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Retrospective analysis of nontuberculosis pleural effusion cases Source: Eur Respir J 2006; 28: Suppl. 50, 579s Year: 2006
Chemical pleurodesis for malignant pleural effusion: a comparative study Source: Eur Respir J 2006; 28: Suppl. 50, 51s Year: 2006
Retrospective analysis of 455 pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 447s Year: 2005
Real life diagnosis in pleural effusion: a retrospective survey Source: Eur Respir J 2006; 28: Suppl. 50, 580s Year: 2006
Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 50s Year: 2006
Thoracentesis in the bilateral pleural effusion. Should we puncture both sides? Prospective study Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015
Cytology and blind biopsies in the diagnosis of pleural effusion Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012